Immune, Gene and Cell Therapy
Course Start: September 14, 2026
(3MG018) The course gives an overview of new and established treatments based on immune, gene and cell therapy. The course will discuss new opportunities as well as difficulties with these kinds of therapies. Some areas that will be at focus are transplantation of endocrine cells, immunotherapy of cancer and stem cell transplantation. The course is a seminar series consisting of ten meetings. The seminars will be held by scientists and/or medical doctors in the field.
Course info
- Type: University Course
- Organization: Uppsala University
- Start Date: September 14, 2026
- Language: English
- Place: Uppsala
Photo: David Naylor | Uppsala Universitetshus
Learning outcomes
Knowledge and understanding
On completing the course, the students shall be able to:
- provide examples of diseases that can be treated with immune therapy, gene therapy and cell therapy,
- explain some of the roles the immune system plays in cancer, in immune-mediated diseases such as allergy and autoimmunity and in transplantation,
- give examples and explain different technologies used in immune therapy, gene therapy and cell therapy.
Competence and skills
On completing the course, the students shall demonstrate the ability to:
- summarize and evaluate scientific articles within the subjects of immune therapy, gene therapy and cell therapy,
- present in written form an independently chosen topic within the field of immunotherapy, gene therapy and cell therapy.
Judgement and approach
On completing the course, the students shall demonstrate the ability to:
- identify knowledge gaps and need for further research within a topic in the field of immune therapy, gene therapy or cell therapy,
- critically review and argue about ethical and social aspects of using immune, gene or cell therapy.
Project code: 3MG018
Course format: University Master’s Level
Course duration: 7.5 ECTS, 50%